New research1,2,3 shows many dental mouthwashes destroy the lipid layer of coronaviruses and reduces the replication of the virus in the throat and salivary glands, making mouthwash a potentially useful prophylactic against COVID-19. As noted by the authors:4 “Emerging studies increasingly demonstrate the importance of the throat and salivary glands as sites of virus replication… Read More »
A new study using a roundworm model of Parkinson’s disease found that a probiotic bacterium could prevent, and in some cases reverse, toxic protein buildup. Misfolded alpha-synuclein proteins in the brain are the hallmark sign of Parkinson’s disease. Many experts believe that these toxic protein clumps lead to the progressive loss of brain cells that… Read More »
THURSDAY, May 21, 2020 — A combination drug therapy for COVID-19 aims to both prevent the virus from spreading inside the human body as well as quelling the immune system havoc that the germ wreaks. A U.S. federally funded clinical trial is testing whether the experimental antiviral drug remdesivir works better against COVID-19 if given… Read More »
A PrEP programme targeting 5% of gay and bisexual men in the Netherlands would not only cause big reductions in HIV incidence, but would lead to even greater reductions in gonorrhoea. In the ’base case’ of the model, gonorrhoea would almost be almost eliminated, with 2027 only having 3% of the infections seen in 2018, the… Read More »
Partners HealthCare System Inc., in the Boston area, in 2012 acquired a nonprofit Medicaid insurer, Neighborhood Health Plan, and after a few years moved into commercial health insurance for employers, even as losses mounted. During the six fiscal years ended Sept. 30, 2019, the insurance unit, now called AllWays Health Partners Inc., reported $ 299… Read More »